Published in J Am Coll Cardiol on March 01, 1995
New advances in the management of acute coronary syndromes: 1. Matching treatment to risk. CMAJ (2001) 2.12
Safe discharge from the cardiac emergency room with a rapid rule-out myocardial infarction protocol using serial CK-MB(mass). Heart (2001) 0.89
Multimarker Risk Stratification in Patients With Acute Myocardial Infarction. J Am Heart Assoc (2016) 0.88
Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers. Heart (2003) 0.86
Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction. Exp Biol Med (Maywood) (2015) 0.79
Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart (2004) 0.79
Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction. Clin Res Cardiol (2015) 0.76
Cardiac troponin T in unstable angina. Does measurement of troponin T add to ability to stratify risk? BMJ (1996) 0.75
Cardiac troponin T in unstable angina. Troponin T could be used to identify patients needing early treatment. BMJ (1996) 0.75
Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories. Toxicol Pathol (2016) 0.75
The reporting of cardiac troponin. Clin Biochem Rev (2003) 0.75
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol (2000) 16.47
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation (2000) 2.49
Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med (1990) 2.15
International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem (1986) 1.51
Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J (2001) 1.46
The natural history of insulin-dependent diabetes mellitus in Denmark: 1. Long-term survival with and without late diabetic complications. Diabet Med (1987) 1.34
International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem (1986) 1.26
Mode of death in heart failure: findings from the ATLAS trial. Heart (2003) 1.24
Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation (1997) 1.23
An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes (1998) 1.19
Sphingomyelinase is part of the 'enterotoxin complex' produced by Bacillus cereus. FEMS Microbiol Lett (1993) 1.07
Perioperative myocardial ischaemia in patients undergoing surgery for fractured hip randomized to incremental spinal, single-dose spinal or general anaesthesia. Eur J Anaesthesiol (1998) 1.06
Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE). Scand J Clin Lab Invest (1979) 1.06
Biochemical markers of ischaemia for the early identification of acute myocardial infarction without St segment elevation. Cardiology (2000) 1.06
Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest (1993) 1.02
International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem (1980) 1.00
Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet (2004) 0.97
Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group. Circulation (1998) 0.95
Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol (Copenh) (1980) 0.93
Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia. Acta Neurol Scand (2013) 0.93
Addition of 2.5% lactate and 0.25% acetate controls growth of Listeria monocytogenes in vacuum-packed, sensory-acceptable servelat sausage and cooked ham stored at 4 degrees C. Int J Food Microbiol (1997) 0.93
Effects of posture on concentrations of blood constituents in healthy adults: practical application of blood specimen collection procedures recommended by the Scandinavian Committee on Reference Values. Scand J Clin Lab Invest (1980) 0.93
High levels of background flora inhibits growth of Escherichia coli O157:H7 in ground beef. Int J Food Microbiol (2000) 0.92
Pre-hospital treatment of STEMI patients. A scientific statement of the Working Group Acute Cardiac Care of the European Society of Cardiology. Acute Card Care (2011) 0.92
Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group. Ann Med (2001) 0.92
The storage life of beef and pork packaged in an atmosphere with low carbon monoxide and high carbon dioxide. Meat Sci (1999) 0.92
31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes. Biochim Biophys Acta (1990) 0.92
Falsely negative urinary leucocyte counts due to delayed examination. Scand J Clin Lab Invest (1980) 0.92
Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction. Am Heart J (1994) 0.91
Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population. Hum Mutat (1997) 0.90
The stability of blood, plasma and serum constituents during simulated transport. Scand J Clin Lab Invest (1981) 0.90
Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II. Calcif Tissue Int (1991) 0.89
Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J (1994) 0.89
Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest (1992) 0.87
Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction. Pharmacogenetics (1998) 0.86
Long-term survival after myocardial infarction as related to early complications. Eur J Cardiol (1978) 0.86
Magnesium inhibits platelet activity--an infusion study in healthy volunteers. Thromb Haemost (1996) 0.86
Current trends in the collaboration of primary health care and clinical chemistry in the Nordic countries. Ups J Med Sci (1986) 0.85
Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone (1998) 0.85
Detection of a single base deletion in codon 424 of the low density lipoprotein receptor gene in a Danish family with familial hypercholesterolemia. Atherosclerosis (1994) 0.85
Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril. Circulation (1994) 0.85
Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Br J Clin Pharmacol (1999) 0.84
Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest (1988) 0.84
Molecular genetics of familial hypercholesterolemia in Israel. Hum Genet (1996) 0.84
Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation (1993) 0.84
Gene dosage and down-regulation of the alpha-interferon receptor. Scand J Clin Lab Invest (1992) 0.83
Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB. Br Heart J (1991) 0.83
Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet (2000) 0.83
Changes in polyphosphate composition and localization in Propionibacterium acnes after near-ultraviolet irradiation. Can J Microbiol (1991) 0.83
Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients. Cardiology (1992) 0.82
Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat (1996) 0.81
Time course of myocardial viability after acute myocardial infarction: an echocardiographic study. Am Heart J (1998) 0.81
[Plasma level and half-life of proscillaridine in healthy and renal failure persons]. Verh Dtsch Ges Inn Med (1973) 0.81
Admission risk assessment by cardiac troponin T in unstable coronary artery disease: additional prognostic information from continuous ST segment monitoring. TRIM study group. Thrombin Inhibition in Myocardial Ischemia. J Am Coll Cardiol (1999) 0.81
Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B. Clin Genet (1998) 0.80
Variability of plasma proteins according to molecular size. Long-term and short-term intra-individual variation. Scand J Clin Lab Invest (1981) 0.80
Early administration of intravenous magnesium inhibits arterial thrombus formation. Arterioscler Thromb Vasc Biol (1997) 0.80
Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia. Clin Genet (2006) 0.80
31P NMR measurements of intracellular pH in erythrocytes: direct comparison with measurements using freeze-thaw and investigation into the influence of ionic strength and Mg2+. Magn Reson Med (1987) 0.80
Temporal and positional variability of the ST segment during continuous vectorcardiography monitoring in healthy subjects. J Electrocardiol (1999) 0.80
Incidence and prognostic significance of intraventricular block in acute myocardial infarction. Cardiology (1979) 0.80
A dual label oligonucleotide ligation assay for detection of the CYP2C19*1, CYP2C19*2, and CYP2C19*3 alleles involving time-resolved fluorometry. Ther Drug Monit (1998) 0.79
Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB. Clin Chem (1990) 0.79
Long term risk stratification of patients with acute coronary syndromes: characteristics of troponin T testing and continuous ST segment monitoring. Heart (2004) 0.79
Creatine kinase and creatine kinase B-subunit in stable and unstable angina pectoris. Eur J Clin Invest (1986) 0.79
Predominance of a 6 bp deletion in exon 2 of the LDL receptor gene in Africans with familial hypercholesterolaemia. J Med Genet (2000) 0.79
Effects of captopril on left ventricular systolic and diastolic function after acute myocardial infarction. Am J Cardiol (1992) 0.79
Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor. J Urol (1988) 0.79
Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia. Hum Mutat (2001) 0.79
[Effect of 2- and 5-isosorbide nononitrate on the exercise-ECG of patients with coronary insufficiency]. Verh Dtsch Ges Kreislaufforsch (1975) 0.79
Ways of assessing quality goals for diagnostic tests in clinical situations. Arch Pathol Lab Med (1988) 0.78
Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation. Scand J Clin Lab Invest (1996) 0.78
Assessment of the NMR visibility of intraerythrocytic sodium by flame photometric and ion-competitive studies. Magn Reson Med (1989) 0.78
Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations. Scand J Clin Lab Invest (2005) 0.78
Effects of posture on concentrations of serum proteins in healthy adults. Dependence on the molecular size of proteins. Scand J Clin Lab Invest (1980) 0.78
Selenium status and the effect of organic and inorganic selenium supplementation in a group of elderly people in Denmark. Scand J Clin Lab Invest (1994) 0.78
Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. Scand J Clin Lab Invest (1981) 0.78
[Laboratory medicine in primary health care--extent and costs]. Nord Med (1988) 0.78
Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat (1997) 0.78
[Congenital defects of the left-sided pericardium]. Z Kardiol (1976) 0.78
Production and certification of an enzyme reference material for adenosine deaminase 1 (BCR 647). Clin Chim Acta (2001) 0.78
Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med (1991) 0.77
Reference values for six enzymes in plasma from newborns and women at delivery. Scand J Clin Lab Invest (1979) 0.77
Discrepancies in assessment of metabolic regulation in insulin-dependent diabetes mellitus--can we do without measurements of glycated haemoglobin? Diabetes Res (1990) 0.77
Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia. Am J Med Genet (1996) 0.77
Fluoride, aluminum, and phosphate kinetics in cryolite workers. J Occup Med (1990) 0.77
Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants. Atherosclerosis (1997) 0.77
Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2. Anticancer Res (1998) 0.77
The influence of analytical bias on diagnostic misclassifications. Clin Chim Acta (1997) 0.77
Higher sensitivity troponin assays: Quo vadis? Eur Heart J (2008) 0.77